News

Peer-to-peer network enables docs to discuss drug performance, especially of new launches

Trade association is now big companies with big R&D spending

Pharmaceutical Commerce’s annual Cold Chain Sourcebook projects moderating growth of 38% between 2015 and 2021

Company says it owns 2/3rds of the global life sciences CRM market for core salesforce automation

Takes reins with prior experience at both FDA and HHS

Leading supplier of software for DSCSA compliance builds a master data repository

Latest QuintilesIMS report sees 5.8% growth in 2016; more emphasis on ‘net-price’ spending

Containers and data monitoring for cell-therapy and related biologic materials

Fast reimbursement of trial subjects—a boost to trial participation—is compromised

Wholesaler-led initiative tags ValueCentric to build an industry data repository; sign in for an April 28 webinar

UPS-owned subsidiary expands its direct-to-patient clinical services

Software/data offering will unify a ‘molecule to market’ solution for life sciences companies

The TransCelerate consortium is an early adopter

Acquisition of PharmaMetrics adds payer analytics to Integrichain’s channel, pharmacy intelligence

‘Why fund your competitors?’ asks the company, in a pitch to independents served by the Big 3 wholesalers

Less drug waste, fewer ER visits can offset high drug costs

Earns a “50+ Innovation Leader” award by AARP and MedCity News

$6.1-billion acquisition of Medtronic assets for patient care consumables

Cutting Edge report finds continued growth in headcount

Clients can choose new capacity in CRT, refrigerated and deep-frozen ranges

A growing process burden is forcing a modernized approach

‘Future proof’ your implementation by adhering to industry standards

Addressing patient recruitment and retention issues is a natural role for CTEs

Management of controlled room-temperature shipments generates rising demand

Reimbursement is just one of the issues facing biosimilar commercialization in the US

Despite the buzz around digital media channels, pharma continues to pour marketing dollars into television